A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal Cancers
Clinical trial NCT06760702 · TERMINATED
Trial details
- NCT number
- NCT06760702
- Sponsor
- Aurigene Discovery Technologies Limited
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-09
- Primary completion
- 2026-02-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.